In conclusion, reactivation of RORα could serve as a therapeutic strategy for MYCN-amplified NBs by blocking the dysregulation of molecular clock and cell metabolism mediated by MYCN. This evidence concerns the gene RORA and Nijmegen breakage syndrome.